Nolan Sean P. sold TSHA

January 26, 2026 · Form 4 insider transaction

Nolan Sean P. sold 41,312 shares of Taysha Gene Therapies, Inc. at $4.61 per share, a transaction worth $190.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
41,312
Price
$4.61
Total value
$190.4K
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 26, 2026
Filing dateJanuary 27, 2026
Shares owned after2,908,257
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only.; The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.505 to $4.715 inclusive.

View the original Form 4 on SEC EDGAR